Ambulatory infusion centers provide intravenous (IV) medical therapies in an outpatient setting, allowing patients to receive prescription medications or infused medications and therapies in a more convenient and cost-effective manner. They provide many advantageous treatments such as chemotherapy, hydration therapy, antibiotics, pain management, and other therapies that aim to improve patient health and quality of life. The global ambulatory infusion center market offers a safe alternative to hospital-based infusion treatments, providing patients with privacy and comfort while receiving IV treatments. The global Ambulatory Infusion Center Market is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the ambulatory infusion center market is the shift towards convenient care facilities. With the rising geriatric population globally, there is a growing demand for convenient outpatient care services to avoid unnecessary hospital admissions. Ambulatory infusion centers provide a comfortable environment for patients to receive IV treatments without staying overnight in hospitals. This has boosted the preference for ambulatory infusion centers over traditional hospital-based outpatient departments or physician offices. Their growing network is making high-quality infusion services more accessible to patients.

Porter’s Analysis

Threat of new entrants: The threat of new entrants in the ambulatory infusion center market is low as it requires high capital investments and expertise to set up dedicated infusion centers.

Bargaining power of buyers: The bargaining power of buyers is moderate as the availability of large healthcare providers and ambulatory infusion centers provides options to buyers.

Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of substitutes and lack of differentiation between products.

Threat of new substitutes: The threat of new substitutes is moderate as new drug delivery methods can be introduced.

Competitive rivalry: Competition in the market is high as the key players compete on the basis of service quality, reliability, and pricing.

Key Takeaways

The Global Ambulatory Infusion Center Market Size is expected to witness high growth over the forecast period. North America region is expected to dominate the market during the forecast period attributed to the growing geriatric population and increasing prevalence of chronic diseases. Key players operating in the ambulatory infusion center market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare.

Regional analysis: North America region is dominating the market due to increasing patient pool, rising prevalence of chronic diseases, and growing preference for ambulatory infusion therapy over conventional hospital care. Asia Pacific is expected grow at the fastest pace during the forecast period owing to growing healthcare infrastructure and increasing healthcare spending in countries like China and India.

Key players: Key players operating in the ambulatory infusion center market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare. These players are focusing on strategies such as partnerships, service expansion, and mergers and acquisitions to expand their presence and services across various regions.